Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Insulin glargine (Lantus).

D R Owens1, S Griffiths

  • 1Diabetes Research Unit, University of Wales College of Medicine, Cardiff, UK. owensdr@cardiff.ac.uk

International Journal of Clinical Practice
|August 9, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Testing the sociocultural model of eating disorders: A cross-national analysis of income inequality, gender equality, and eating disorder rates.

Social science & medicine (1982)·2026
Same author

Traumatic Experiences, Psychological Distress and Suicide-Related Behaviors in Autistic Adults.

Autism research : official journal of the International Society for Autism Research·2025
Same author

Comparing in-person and remote consent of people with dementia into a primary care-based cluster randomised controlled trial: lessons from the Dementia PersonAlised Care Team (D-PACT) feasibility study.

BMC medical research methodology·2025
Same author

IDF diabetes Atlas: A worldwide review of studies utilizing retinal photography to screen for diabetic retinopathy from 2017 to 2024 inclusive.

Diabetes research and clinical practice·2025
Same author

Is #bodypositivity influential for sexual minority men? An ecological momentary assessment study on the effects of viewing body positivity content on social media.

Body image·2025
Same author

Affective Trajectories of Binge Eating, Purging, and Exercise Among Sexual Minority Men.

The International journal of eating disorders·2025
Same journal

RETRACTION: Prediction of Arrhythmia Recurrence after Atrial Fibrillation Ablation in Patients with Normal Anatomy of the Left Atrium.

International journal of clinical practice·2025
Same journal

Clinical Outcomes Based on the Attainment of Low-Density Lipoprotein Cholesterol Targets in Patients with Acute Coronary Syndrome in Real-World Practice.

International journal of clinical practice·2025
Same journal

Knowledge and Awareness of Osteoporosis: A Survey of Physical Therapy Providers in Saudi Arabia.

International journal of clinical practice·2024
Same journal

Efficacy and Safety of Pericapsular Nerve Group Block for Hip Fracture Surgery under Spinal Anesthesia: A Meta-Analysis.

International journal of clinical practice·2024
Same journal

The Role of Pharmaceutical Innovation in Clinical Practice Guidelines for Chronic Diseases.

International journal of clinical practice·2024
Same journal

Blood Features Associated with Viral Infection Severity: An Experience from COVID-19-Pandemic Patients Hospitalized in the Center of Iran, Yazd.

International journal of clinical practice·2024
See all related articles

Insulin glargine offers improved basal insulin therapy for diabetes, providing steady insulin levels without peaks. It achieves similar glycemic control to NPH insulin but with significantly less hypoglycemia, especially at night.

Area of Science:

  • Endocrinology
  • Pharmacology

Background:

  • Traditional intermediate-acting insulins like NPH insulin have limitations for basal insulin supplementation.
  • Insulin glargine is a long-acting human insulin analogue designed to address these deficiencies.

Purpose of the Study:

  • To evaluate the efficacy and safety of insulin glargine compared to NPH insulin for basal insulin supplementation in patients with type 1 and type 2 diabetes.
  • To assess glycaemic control, fasting blood glucose levels, and the incidence of hypoglycemia.

Main Methods:

  • Comparison of once-daily insulin glargine with NPH insulin (once or twice daily) in patients with type 1 and type 2 diabetes.
  • Assessment of glycaemic control, fasting blood glucose, and hypoglycaemic episodes.

Main Results:

Related Experiment Videos

  • Insulin glargine achieved equivalent glycaemic control to NPH insulin.
  • Significantly lower fasting blood glucose levels were observed with insulin glargine in type 1 diabetes patients.
  • Insulin glargine was associated with less hypoglycemia, particularly nocturnal episodes, compared to NPH insulin.
  • Higher treatment satisfaction was reported by patients using insulin glargine.

Conclusions:

  • Insulin glargine provides effective and safer basal insulin therapy than NPH insulin, with a reduced risk of hypoglycemia.
  • Individualized dosing is crucial for achieving target blood glucose levels without hypoglycemia.
  • Insulin glargine can be used in combination with short-acting insulins or oral agents, and early introduction in type 2 diabetes is recommended.